WEG STUART L has a total of 37 patent applications. Its first patent ever was published in 1995. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, medical technology and foods and drinks are JOHNSON B RON, ACERUS PHARMACEUTICALS SRL and EDGE THERAPEUTICS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Mexico | 4 | |
#6 | Australia | 3 | |
#7 | China | 2 | |
#8 | Japan | 2 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Enzymes | |
#4 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Weg Stuart L | 34 |
#2 | Mermelstein Fred H | 2 |
#3 | Albin Randi | 2 |
Publication | Filing date | Title |
---|---|---|
AU2013305580A1 | Anxiolytic composition, formulation and method of use | |
US2009143436A1 | Anesthetic composition, formulation and method of use | |
EP1983827A2 | Use of antifungal compositions to treat upper gastrointestinal conditions | |
WO9707750A1 | Administration of ketamine to manage pain and to reduce drug dependency | |
CA2213567A1 | Use of ketamine for facilitating detoxification and treatment of smoking addiction, and device therefor | |
CA2596947A1 | Nasal and ocular administration of ketamine to manage pain and for detoxification | |
MX9706456A | Nasal and ocular administration of ketamine to manage pain and for detoxification. | |
EP0751766A1 | Nasal and ocular administration of ketamine to manage pain and for detoxification |